Search clinical trials for: Typhoid Vi vaccine

Total 6346 results

International Vaccine Institute
SK Chemicals Co., Ltd.

Completed

Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

Typhoid
University of Illinois at Chicago

Terminated

Effect of Age and Fitness on Vascular Function and Oxidative Stress During Acute Inflammation

Inflammation | Aging

United States
PT Bio Farma

Completed

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Safety Issues | Immunogenicity

Indonesia
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

Bacterial Infections | Typhoid Fever | Salmonella Infections

Japan
Matrivax Research and Development Corporation

Completed

Safety and Immunogenicity of Typhax, a Typhoid Vaccine

Typhoid Fever
University of Virginia
CSL Behring; Jeffrey Modell Foundation

Completed

Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency

Immune Deficiency

United States
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

Safety Issues | Immunogenicity

Indonesia
International Vaccine Institute
SK Bioscience Co., Ltd.

Unknown

Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine

Typhoid

Nepal
University of Oxford

Completed

Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers

Typhoid Vaccine on Sleep
University of Maryland, Baltimore
Bill and Melinda Gates Foundation; Groupe de Recherche Action en Sante

Completed

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Typhoid

Burkina Faso
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort (SLVP033)

Hepatitis A | Influenza | Healthy Adults | Typhoid

United States
University of Maryland, Baltimore
University College, London; Bill and Melinda Gates Foundation; Malawi-Liverpool-Wellcome... and other collaborators

Active, not recruiting

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Typhoid

Malawi
International Centre for Diarrhoeal Disease Research...

Recruiting

Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh

Typhoid

Bangladesh
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

Inflammation and Threat Sensitivity in PTSD (K01)

Posttraumatic Stress Disorder

United States
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

Cognitive, Emotional, and Neural Responses to Acute Inflammation

Healthy

United States
Queen Mary University of London

Completed

Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation

Cardiovascular Diseases

United Kingdom
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
Janssen Pharmaceutica N.V., Belgium

Completed

Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

Major Depressive Disorder

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Disease

Vietnam
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; National Institute of Hygiene and Epidemiology... and other collaborators

Completed

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

Typhoid | Paratyphoid Fever

Vietnam
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; University of Western Ontario, Canada; National...

Completed

Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Typhoid | Paratyphoid Fever

India
International Vaccine Institute
Wellcome Trust; Centers for Disease Control and Prevention; University of Western... and other collaborators

Completed

Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

Typhoid | Paratyphoid Fever

China
PT Bio Farma
Indonesia University

Active, not recruiting

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

Vaccine

Indonesia
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; Aga Khan University; University of Western Ontario...

Completed

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

Typhoid | Paratyphoid Fever

Pakistan
University of Oxford
Mahidol University; Ministry of Health, Thailand

Recruiting

Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity

Iron Deficiency Anemia

Thailand
GlaxoSmithKline

Completed

Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

Hepatitis A
EuBiologics Co.,Ltd

Completed

Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants

Typhoid Fever

Philippines
International Vaccine Institute
Bill and Melinda Gates Foundation; SK Bioscience Co., Ltd.

Completed

Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)

Typhoid

Philippines
GlaxoSmithKline
Bill and Melinda Gates Foundation; Wellcome Trust; Biomedical Advanced Research... and other collaborators

Recruiting

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

Salmonella Infections

Belgium, Malawi
Eunice Kennedy Shriver National Institute of Child...

Completed

Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants

Typhoid Fever

Vietnam
Novartis
Novartis Vaccines

Completed

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Japanese Encephalitis | Rabies | Yellow Fever | Meningococcal Disease | Typhoid | Meningococcal Meningitis

Czech Republic, Germany
Queen Mary University of London

Completed

Investigation of the Influence of Gender on Cardiovascular Function

Cardiovascular Function

United Kingdom
International Vaccine Institute
Bill and Melinda Gates Foundation; SK Bioscience Co., Ltd.

Completed

Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine

Typhoid

Philippines
National Institute of Allergy and Infectious Diseases...

Completed

Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali

Malaria

Mali
McMaster University

Not yet recruiting

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT (SMART)

Monkeypox

Nigeria, Congo, The Democratic Republic of the, Uganda
Swiss Federal Institute of Technology
University of Oxford; Jomo Kenyatta University of Agriculture and Technology

Recruiting

Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women (DIVA_II)

Iron Deficiency Anemia

Kenya
University of Maryland, Baltimore

Active, not recruiting

CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults

Typhoid Vaccination

United States
University of Oxford

Completed

Vaccines Against Salmonella Typhi (VAST)

Typhoid Fever | Enteric Fever

United Kingdom
University of Maryland, Baltimore

Recruiting

Blood Donor CVD 5000

Risk Reduction

United States
University of Maryland, Baltimore

Recruiting

CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera

Typhoid and/or Cholera Vaccination

United States
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Safety Issues

Indonesia
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Typhoid Fever

Philippines
Prof Simon Karanja
University of Oxford; Swiss Federal Institute of Technology

Recruiting

Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women

Iron Deficiency Anemia

Kenya
GlaxoSmithKline

Recruiting

A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants

Diarrhoea

Belgium, Kenya
Radboud University Medical Center

Completed

Role of BCG as Booster Vaccination

BCG Vaccination

Netherlands
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants

Typhoid Fever

Pakistan, India
Stanford University
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; World Health Organization and other collaborators

Completed

Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India

Typhoid Fever | Enteric Fever | Salmonella Typhi Infection

India
Karolinska Institutet
University Hospital, Linkoeping

Completed

Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers

Myocardial Infarction | Inflammation | Reperfusion Injury | Acute Coronary Syndrome (ACS)

Sweden
International Centre for Diarrhoeal Disease Research...
Centers for Disease Control and Prevention

Not yet recruiting

Co-administration Study of OCV, TCV and MR

Measles | Rubella | Cholera | Typhoid
Novartis

Completed

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Typhoid Fever

Belgium

Search clinical trials for: Typhoid Vi vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations